{"database":"biostudies-literature","file_versions":[],"scores":null,"additional":{"omics_type":["Unknown"],"volume":["30(8)"],"submitter":["Freeman CL"],"funding":["NCI NIH HHS"],"journal":["Leukemia"],"pagination":["1763-6"],"full_dataset_link":["https://www.ebi.ac.uk/biostudies/studies/S-EPMC4980557"],"repository":["biostudies-literature"],"pubmed_title":["Role of CD20 expression and other pre-treatment risk factors in the development of infusion-related reactions in patients with CLL treated with obinutuzumab."],"pmcid":["PMC4980557"],"funding_grant_id":["P01 CA081534"],"pubmed_authors":["Kreuzer KA","Fingerle-Rowson G","Humphrey K","Gribben J","Hallek M","Iglesias V","Goede V","de Costa CS","Houghton R","Herling M","Dixon M","Stilgenbauer S","Bottcher S","Freeman CL"],"additional_accession":[]},"is_claimable":false,"name":"Role of CD20 expression and other pre-treatment risk factors in the development of infusion-related reactions in patients with CLL treated with obinutuzumab.","description":null,"dates":{"release":"2016-01-01T00:00:00Z","publication":"2016 Aug","modification":"2026-04-15T17:27:47.987Z","creation":"2024-11-12T19:21:30.58Z"},"accession":"S-EPMC4980557","cross_references":{"pubmed":["26979130"],"doi":["10.1038/leu.2016.41"]}}